-
Choline C-11 Injection Finds Prostate Cancer
Share this:
Each year about 90,000 men seek treatment for recurrent prostate cancer, and evaluating them for recurrence is a major challenge. Physicians have to wait until a patient’s prostate-specific antigen (PSA) levels rise to a certain level to identify sites of the recurrence.
Now Mayo Clinic has received U.S. Food and Drug Administration approval to produce and administer Choline C-11 Injection, an imaging agent used during a positron emission tomography (PET) scan to help detect sites of recurrent prostate cancer.
Click here for news release
Animation, b-roll and sound bites with Eugene Kwon, M.D. and Val Lowe, M.D. are available in the downloads.
Expert titles for broadcast cg:
Dr. Eugene Kwon, Mayo Clinic Urologist
Dr. Val Lowe, Mayo Clinic Radiologist
Share this:
Related articles
September is Thyroid Cancer Awareness Month, which makes this a good time to learn about treating thyroid cancer. Nearly 44,000 new cases of thyroid cancer will be diagnosed ...
You might need supplemental screenings if you've been diagnosed with dense breast tissue. Women with dense breast tissue have less fat and more glandular and ...
The types of cancer that occur in children often are different from those in adults. Childhood cancers usually are not linked to lifestyle or environmental ...